XTX Topco Ltd - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$54,986
+111.7%
36,657
+124.4%
0.01%
+80.0%
Q2 2023$25,968
-79.2%
16,332
-87.6%
0.01%
-83.9%
Q3 2022$125,000
+177.8%
132,070
+249.7%
0.03%
+72.2%
Q2 2022$45,000
-11.8%
37,770
+29.8%
0.02%
-37.9%
Q4 2021$51,00029,1090.03%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders